The United States market has experienced a robust climb, with a 2.3% increase in the last week and a significant 25% rise over the past year, while earnings are projected to grow by 19% annually. Amidst these favorable conditions, identifying stocks that combine affordability with growth potential is key, especially when considering penny stocks. Although the term 'penny stock' might seem outdated, these smaller or newer companies can still offer substantial opportunities for investors who focus on those with solid financial foundations and promising prospects.

Let's explore several standout options from the results in the screener.

AlTi Global (ALTI)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: AlTi Global, Inc. is a company that offers wealth and asset management services across various international markets including France, Hong Kong, Italy, Portugal, Singapore, Switzerland, the United Kingdom, and the United States with a market cap of $432.91 million.

Operations: The company generates revenue primarily from its Wealth & Capital Solutions segment, which accounts for $270.97 million.

Market Cap: $432.91M

AlTi Global, Inc. has been navigating significant changes, including leadership shifts with Nancy Curtin stepping in as interim CEO following Michael Tiedemann's departure. The company reported first-quarter 2026 revenues of US$73.11 million, up from US$57.09 million the previous year, indicating growth despite ongoing unprofitability and a negative return on equity of -13.53%. AlTi's recent partnership to deploy Nevis AI aims to enhance operational efficiency in wealth management services globally. While its short-term assets exceed liabilities, long-term liabilities remain uncovered by current assets, posing potential financial challenges ahead.

Vuzix (VUZI)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Vuzix Corporation designs, manufactures, and markets AI-powered smart glasses, waveguides, and augmented reality technologies globally with a market cap of $282.74 million.

Operations: The company's revenue is primarily generated from its video eyewear products, amounting to $6.09 million.

Market Cap: $282.74M

Vuzix Corporation, with a market cap of US$282.74 million, is actively showcasing its advanced waveguide solutions and smart glasses across various industry events, highlighting its capabilities in defense and enterprise applications. Despite generating US$1.39 million in revenue for Q1 2026, the company remains unprofitable with a net loss of US$7.07 million. Vuzix's short-term assets significantly exceed liabilities, yet it faces challenges due to high share price volatility and significant insider selling recently. The company's seasoned management team continues to drive product innovation while navigating financial constraints with less than a year of cash runway remaining.

Spero Therapeutics (SPRO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel treatments for multi-drug resistant bacterial infections and rare diseases in the United States, with a market cap of $168.49 million.

Operations: The company's revenue is primarily generated from its novel treatments for multi-drug resistant bacterial infections, totaling $61.19 million.

Market Cap: $168.49M

Spero Therapeutics, Inc., with a market cap of US$168.49 million, has transitioned to profitability over the past year despite recent revenue fluctuations. The company reported Q1 2026 revenue of US$0.258 million, a significant decrease from the previous year's US$5.87 million for the same period, but managed to reduce its net loss from US$13.87 million to US$7.2 million year-over-year. Spero's financial health is bolstered by its debt-free status and strong asset position, with short-term assets of US$57.6 million surpassing both short-term and long-term liabilities significantly while maintaining high-quality earnings growth in a volatile market segment.

Seize The Opportunity

• Unlock our comprehensive list of 335 US Penny Stocks by clicking here.
• Looking For Alternative Opportunities? Trump has pledged to "unleash" American oil and gas and these 23 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.